Science, Discovery, Tech and Environment · 26 February 2026
DBT-ISRO MoU pushes India into space biotechnology and space medicine.
Exam-focused facts from the 26 February 2026 current affairs briefing.
Key facts
- An MoU between the Department of Biotechnology (DBT) and the Indian Space Research Organisation (ISRO) has formally entered India into space biotechnology and space medicine.
- Biotechnology experiments conducted in space missions include studies related to life sciences and muscle physiology.
- The GenomeIndia Project has released whole genome sequencing data of 10,000 individuals from 99 diverse populations through the Indian Biological Data Centre.
- India’s first human gene therapy trial for Severe Hemophilia A—supported by DBT and Biotechnology Industry Research Assistance Council (BIRAC)—achieved sustained Factor VIII production and reduced dependence on repeated infusions.